Drugs for COVID-19: An Update

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Dec 11

PMID 36500655

Authors

Jessica Ceramella

Domenico Iacopetta

Maria Stefania Sinicropi

Inmaculada Andreu

Annaluisa Mariconda

Carmela Saturnino

Federica Giuzio

Pasquale Longo

Stefano Aquaro

Alessia Catalano

Affiliations

Soon will be listed here.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19.

Citing Articles

New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs.

Marra M, Catalano A, Sinicropi M, Ceramella J, Iacopetta D, Salpini R Viruses. 2024; 16(9).

PMID: 39339960 PMC: 11437459. DOI: 10.3390/v16091484.

-An Extensive Review Focused on Recent Studies.

Catalano A, Ceramella J, Iacopetta D, Marra M, Conforti F, Lupi F Foods. 2024; 13(13).

PMID: 38998660 PMC: 11241682. DOI: 10.3390/foods13132155.

Alkalinization Using Sodium Bicarbonate for COVID-19 Treatment: A Systematic Review and Meta-Analysis.

Shafiee A, Jafarabady K, Moltazemi H, Amini M, Rafiei M, Akhondi A J Evid Based Integr Med. 2024; 29:2515690X241258403.

PMID: 38826036 PMC: 11145993. DOI: 10.1177/2515690X241258403.

Efficacy and safety of bamlanivimab in patients with COVID-19: A systematic review and meta-analysis.

Amani B, Khodavirdilou L, Rajabkhah K, Kardan Moghaddam V, Akbarzadeh A, Amani B World J Virol. 2024; 13(1):88660.

PMID: 38616851 PMC: 11008398. DOI: 10.5501/wjv.v13.i1.88660.

The Ongoing Impact of COVID-19 on Pediatric Obesity.

Iacopetta D, Catalano A, Ceramella J, Pellegrino M, Marra M, Scali E Pediatr Rep. 2024; 16(1):135-150.

PMID: 38391001 PMC: 10885050. DOI: 10.3390/pediatric16010013.

References

Sharov A, Burkhanova T, Taskin Tok T, Babashkina M, Safin D . Computational Analysis of Molnupiravir. Int J Mol Sci. 2022; 23(3). PMC: 8835990. DOI: 10.3390/ijms23031508. View

Smith C, Maines L, Keller S, Ben-Yair V, Fathi R, Plasse T . Recent Progress in the Development of Opaganib for the Treatment of Covid-19. Drug Des Devel Ther. 2022; 16:2199-2211. PMC: 9288228. DOI: 10.2147/DDDT.S367612. View

Yadav D, Singh D, Han I, Kumar Y, Choi E . Current Potential Therapeutic Approaches against SARS-CoV-2: A Review. Biomedicines. 2021; 9(11). PMC: 8615922. DOI: 10.3390/biomedicines9111620. View

Ye X, Luo Y, Xia S, Sun Q, Ding J, Zhou Y . Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019. Eur Rev Med Pharmacol Sci. 2020; 24(6):3390-3396. DOI: 10.26355/eurrev_202003_20706. View

Akter F, Araf Y, Hosen M . Corticosteroids for COVID-19: worth it or not?. Mol Biol Rep. 2021; 49(1):567-576. PMC: 8511618. DOI: 10.1007/s11033-021-06793-0. View

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

Baron R, Ejnes Y . Physicians Spreading Misinformation on Social Media - Do Right and Wrong Answers Still Exist in Medicine?. N Engl J Med. 2022; 387(1):1-3. DOI: 10.1056/NEJMp2204813. View

Lo H, Hui K, Lai H, He X, Khan K, Kaur S . Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir. ACS Cent Sci. 2021; 7(5):792-802. PMC: 8056950. DOI: 10.1021/acscentsci.0c01186. View

Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis I . Emerging treatment strategies for COVID-19 infection. Clin Exp Med. 2020; 21(2):167-179. PMC: 7598940. DOI: 10.1007/s10238-020-00671-y. View

10.

Akbarzadeh-Khiavi M, Torabi M, Rahbarnia L, Safary A . Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection. Infection. 2021; 50(2):295-308. PMC: 8666469. DOI: 10.1007/s15010-021-01730-6. View

11.

Hassanipour S, Arab-Zozani M, Amani B, Heidarzad F, Fathalipour M, Martinez-de-Hoyo R . The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials. Sci Rep. 2021; 11(1):11022. PMC: 8155021. DOI: 10.1038/s41598-021-90551-6. View

12.

Zhou F, Deng J, Heybati K, Zuo Q, Ali S, Hou W . Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis. Future Virol. 2022; 17(7):463-489. PMC: 9249165. DOI: 10.2217/fvl-2021-0244. View

13.

Abdool Karim S, Devnarain N . Time to Stop Using Ineffective Covid-19 Drugs. N Engl J Med. 2022; 387(7):654-655. DOI: 10.1056/NEJMe2209017. View

14.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

15.

Hung Y, Lee J, Chiu C, Lee C, Tsai P, Hsu I . Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?. Antibiotics (Basel). 2022; 11(2). PMC: 8868411. DOI: 10.3390/antibiotics11020220. View

16.

Catalano A, Iacopetta D, Ceramella J, Scumaci D, Giuzio F, Saturnino C . Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies. Molecules. 2022; 27(3). PMC: 8839222. DOI: 10.3390/molecules27030616. View

17.

Lamback E, Oliveira M, Haddad A, Vieira A, Neto A, Maia T . Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19. Braz J Infect Dis. 2021; 25(2):101549. PMC: 7894091. DOI: 10.1016/j.bjid.2021.101549. View

18.

Echeverria-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco M, De-Antonio Cusco M, Ferrandez O, Horcajada J . Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther. 2020; 19(2):147-163. DOI: 10.1080/14787210.2020.1813024. View

19.

Majumder J, Minko T . Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS J. 2021; 23(1):14. PMC: 7784226. DOI: 10.1208/s12248-020-00532-2. View

20.

Asrani P, Tiwari K, Eapen M, McAlinden K, Haug G, Johansen M . Clinical features and mechanistic insights into drug repurposing for combating COVID-19. Int J Biochem Cell Biol. 2021; 142:106114. PMC: 8570392. DOI: 10.1016/j.biocel.2021.106114. View